Product
Etoricoxib 60 mg
1 clinical trial
2 indications
Indication
ArthritisIndication
RheumatoidClinical trial
A Phase III, Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial to Assess the Relative Efficacy and Tolerability of Two Doses of MK-0663/Etoricoxib in Patients With Rheumatoid ArthritisStatus: Completed, Estimated PCD: 2014-06-09